Another Bristol Myers exec goes to Acadia; David Southwell takes CEO job at ARCH-backed cancer biotech
→ Allyson McMillan-Youngblood has left Bristol Myers Squibb to join Acadia Pharmaceuticals as SVP of its rare disease franchise. She had a 22-year career at Bristol Myers, becoming SVP and business ...
→ Allyson McMillan-Youngblood has left Bristol Myers Squibb to join Acadia Pharmaceuticals as SVP of its rare disease franchise. She had a 22-year career at Bristol Myers, becoming SVP and business ...
